Ulo, Baby Girl N.
HRN: 20-78-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2022
04/19/2022
IV
22MG
Q8
SEPCIS
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes